Azithromycin !
A macrolide that lingers for days in the tissues, so short courses work. Used for atypical pneumonia, chlamydia, trachoma and cholera.
Updated 2026-11-01
The figure shows azithromycin bound in the exit tunnel of the 70S ribosome of Thermus thermophilus, a model bacterium.
Mechanism of action
Azithromycin binds the 23S rRNA of the 50S subunit and blocks the tunnel through which new proteins leave the ribosome; it also hinders assembly of the 50S subunit. Protein synthesis stops and the bacteria cannot grow. It is taken up by tissues and white blood cells and released slowly, so its levels in tissue stay high long after blood levels fall.
- Enters tissues and phagocytes and builds up there
- Binds the 23S rRNA in the 50S exit tunnel
- The growing protein chain is blocked
- Bacteria stop multiplying
Pharmacokinetics
- Absorption
- Oral bioavailability about 38%; tablets can be taken with or without food. Also given by slow IV infusion.
- Distribution
- Extensive uptake into tissues (lung, tonsil, cervix, prostate) and phagocytes.
- Elimination
- Mainly in the bile as unchanged drug.
- Half-life
- Terminal half-life about 68 hours, because of slow release from tissues.
Indications
- Community-acquired pneumonia, including atypical bacteria (Mycoplasma, Chlamydophila, Legionella) Community-acquired pneumonia →
- Urethritis and cervicitis due to Chlamydia trachomatis Chlamydia infection →
- Gonococcal infection, given together with ceftriaxone (WHO list) Gonorrhoea →
- Streptococcal pharyngitis when a β-lactam cannot be used Streptococcal pharyngitis →
- WHO first-choice uses: trachoma, yaws, cholera and typhoid fever; chancroid
Adverse effects
Common
- Diarrhoea, nausea and abdominal pain
- Headache and dizziness
- Pain or redness at the infusion site (IV form)
Contraindications
- Known allergy to azithromycin, erythromycin or any macrolide or ketolide
- Previous cholestatic jaundice or liver dysfunction with azithromycin
Key interactions
- Warfarin
- May increase its anticoagulant effect; prothrombin time is checked.
- Nelfinavir
- Raises azithromycin levels; liver enzymes and hearing are watched.
- Other QT-prolonging drugs
- Additive risk of arrhythmia.
What is monitored
- ECG in patients with QT prolongation, low potassium or magnesium, or heart disease
- Liver tests if symptoms of hepatitis appear
- Stool pattern for C. difficile
Administration and safety
- The IV form is given only as a slow infusion, never as a bolus or intramuscular injection
- Too concentrated an infusion causes local vein reactions: follow the product's dilution instructions
- Sound-alike names: azithromycin and erythromycin are different drugs
Nursing care
- Ask about macrolide allergy and previous liver problems
- Check the infusion site for pain and redness
- Teach to report palpitations, fainting, yellow skin or severe diarrhoea
- In young infants, ask the family to report vomiting or irritability with feeds
Pregnancy and breastfeeding
Available data have not shown a clear risk of major birth defects.
Test yourself
Think of the answer, then tap the question to see it.
Why can azithromycin be given in short courses?
It is taken up by tissues and phagocytes and released slowly, giving a terminal half-life of about three days.
Why does azithromycin have fewer interactions than clarithromycin?
It hardly inhibits CYP3A, while clarithromycin is a strong inhibitor.
Which cardiac effect is checked in a patient with long QT receiving azithromycin?
QT prolongation, which can lead to torsades de pointes.
How is azithromycin used for gonorrhoea on the WHO list?
Together with ceftriaxone, not alone.
Related drugs
Related conditions
← Back to the class: Macrolides
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: DailyMed - AZITHROMYCIN tablet, film coated (DailyMed (U.S. National Library of Medicine), 2026); DailyMed - AZITHROMYCIN MONOHYDRATE injection, powder, lyophilized, for solution (DailyMed (U.S. National Library of Medicine), 2026); Azithromycin: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); eEML - Electronic Essential Medicines List (World Health Organization, 2025).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.